Gen Pharmaceuticals
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Turkey · 201-500 Employees
View Company Info for Free
Overview
Headquarters
2119 Sokak, Ankara, Ankara, 06520, Turke...Phone Number
+90 3122196219Website
www.genilac.com.trRevenue
$58.2 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Gen Pharmaceuticals
GEN İlaç ve Sağlık Ürünleri Sanayi ve Ticaret A.Ş. is one of Turkey's fastest-growing pharmaceutical companies, dedicated to providing global solutions for unmet health needs with an ethical and human-centered approach. Since its establishment in 1998, the company has focused on rare diseases and has developed a wide range of innovative products through significant R&D investments. With over 500 employees and operations in seven countries, GEN aims to be a key global player in the pharmaceutical industry. The company emphasizes high standards in its production facilities and is committed to ethical practices and corporate responsibility.Explore more
Gen Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Gen Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Gen Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Gen Pharmaceuticals launches new products
Check out if Gen Pharmaceuticals is spiking on competitors!
Earning: See what the market has to say on Gen Pharmaceuticals recently announced quarterly report
Gen Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Gen Pharmaceuticals has new funding data
Congratulate Masked Content for being promoted to Masked Content at Gen Pharmaceuticals
Click to see if Gen Pharmaceuticals had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Gen Pharmaceuticals as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Gen Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Gen Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Gen Pharmaceuticals.
Gen Pharmaceuticals Tech Stack
A closer look at the technologies used by Gen Pharmaceuticals
Gen Pharmaceuticals News & Media
GEN and Sulfateq BV Announce Positive Phase 1 Trial Data on Investigational Drug SUL-238 for Alzheimer's and Other Neurodegenerative Diseases
ANKARA, Turkey, July 28, 2025 - (ACN Newswire) - GEN Pharmaceuticals (GENIL.IS), Türkiye's leading specialty pharmaceutical company, announced positive results from its Phase 1 clinical trial evaluating the safety, tolerability, and pharmacokinetics (PK) of first-in-class and novel orally administered mitochondria-directed drug candidate SUL-238 in healthy elderly volunteers. The findings were presented at the Alzheimer's Association International Conference 2025 (AAIC®) in Toronto. This singleGEN Announces Positive Phase 2 Clinical Trial Results for GN-037 Topical Cream in Patients With Mild to Moderate Plaque Psoriasis
ANKARA, Turkey, Sept 25, 2024 - (ACN Newswire) - GEN Pharmaceuticals (GENIL.IS), a leading Turkish pharmaceutical company, has announced the positive results of its Phase 2 clinical trial evaluating the safety and efficacy of its investigational drug, GN-037 topical cream, in treating mild to moderate plaque psoriasis. The findings were presented at Amsterdam's European Academy of Dermatology and Venereology (EADV) 2024 Congress. GEN Pharmaceuticals GEN Pharmaceuticals Manufacturing Facility ThiAlbireo Reports Q1 Financial Results and Business Update
– BylvayTM (odevixibat) commercial readiness on track for anticipated H2 21 launch in U.S. and EU–
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Gen Pharmaceuticals
Sign Up For FreeTo access detailed company insights
GEN İlaç ve Sağlık Ürünleri Sanayi ve Ticaret A.Ş. is one of Turkey's fastest-growing pharmaceutical companies, dedicated to providing global solutions for unmet health needs with an ethical and human-centered approach. Since its establishment in 1998, the company has focused on rare diseases and has developed a wide range of innovative products th... Read More
